Paola Fossa

发表

Modelling the interaction of steroid receptors with endocrine disrupting chemicals

Luciano Milanesi, Erika Salvi, Pasqualina D'Ursi, 2005, BMC Bioinformatics.

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors

Annalisa Salis, Monica Casale, Paola Fossa, 2020, International journal of molecular sciences.

In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanalogues

Fabrizio Giordanetto, Paola Fossa, Giulia Menozzi, 2003, J. Comput. Aided Mol. Des..

Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site

Paola Fossa, Luisa Mosti, Raffaella Boggia, 1998, J. Comput. Aided Mol. Des..

Exploring the molecular basis of selectivity in A1 adenosine receptors agonists: a case study

Fabrizio Giordanetto, Paola Fossa, Giulia Menozzi, 2003, J. Comput. Aided Mol. Des..

New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies.

Silvia Schenone, Paola Fossa, Claudia Martini, 2005, Organic & biomolecular chemistry.

1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.

Silvia Franchini, Paola Fossa, Elena Cichero, 2010, European journal of medicinal chemistry.

Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools.

Annalisa Salis, Gianluca Damonte, Paola Fossa, 2018, European journal of medicinal chemistry.

Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis.

Annalisa Salis, Gianluca Damonte, Paola Fossa, 2015, European journal of medicinal chemistry.

Recent Strategic Advances in CFTR Drug Discovery: An Overview

Alessandro Orro, Pasqualina D'Ursi, Paola Fossa, 2020, International journal of molecular sciences.

Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.

Silvia Schenone, Alessandra Pani, Paola Fossa, 2005, Journal of medicinal chemistry.

Exploitation of a novel biosensor based on the full-length human F508del-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue

Paolo Bergese, Alessandro Orro, Luciano Milanesi, 2019 .

Exploring the QSAR of Pyrazolo[3,4‐b]Pyridine, Pyrazolo[3,4‐b]Pyridone and Pyrazolo[3,4‐b]Pyrimidine Derivatives as Antagonists for A1 Adenosine Receptor

Chiara Casolino, Paola Fossa, Elena Cichero, 2009 .

Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance

Alessandro Orro, Luciano Milanesi, Gabriele Trombetti, 2018, Molecules.

Chemometric Study and Validation Strategies in the Structure-Activity Relationships of New Cardiotonic Agents

Michele Forina, Paola Fossa, Luisa Mosti, 1997 .

Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.

Luciano Milanesi, Anna Marabotti, Pasqualina D'Ursi, 2011, European journal of medicinal chemistry.

Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis

Paola Fossa, Elena Cichero, Giulia Menozzi, 2008, Journal of molecular modeling.

Discovery of a new series of 5-HT1A receptor agonists.

Silvia Franchini, Paola Fossa, A. Prandi, 2010, Bioorganic & medicinal chemistry letters.